196 related articles for article (PubMed ID: 33545548)
1. A chinese herbal formula ameliorates COPD by inhibiting the inflammatory response via downregulation of p65, JNK, and p38.
Li J; Xie Y; Zhao P; Qin Y; Oliver BG; Tian Y; Li S; Wang M; Liu X
Phytomedicine; 2021 Mar; 83():153475. PubMed ID: 33545548
[TBL] [Abstract][Full Text] [Related]
2. Effective-component compatibility of Bufei Yishen formula II inhibits mucus hypersecretion of chronic obstructive pulmonary disease rats by regulating EGFR/PI3K/mTOR signaling.
Li J; Ma J; Tian Y; Zhao P; Liu X; Dong H; Zheng W; Feng S; Zhang L; Wu M; Zhu L; Liu S; Zhao D
J Ethnopharmacol; 2020 Jul; 257():112796. PubMed ID: 32344236
[TBL] [Abstract][Full Text] [Related]
3. Restoring Th17/Treg balance via modulation of STAT3 and STAT5 activation contributes to the amelioration of chronic obstructive pulmonary disease by Bufei Yishen formula.
Zhao P; Li J; Tian Y; Mao J; Liu X; Feng S; Li J; Bian Q; Ji H; Zhang L
J Ethnopharmacol; 2018 May; 217():152-162. PubMed ID: 29454913
[TBL] [Abstract][Full Text] [Related]
4. Effective-Component Compatibility of Bufei Yishen Formula III Combined with Electroacupuncture Suppresses Inflammatory Response in Rats with Chronic Obstructive Pulmonary Disease via Regulating SIRT1/NF-
Jin F; Zhang L; Chen K; Miao Y; Liu Y; Tian Y; Li J
Biomed Res Int; 2022; 2022():3360771. PubMed ID: 35586807
[TBL] [Abstract][Full Text] [Related]
5. Long-term effects of three Tiao-Bu Fei-Shen therapies on NF-κB/TGF-β1/smad2 signaling in rats with chronic obstructive pulmonary disease.
Li Y; Li JS; Li WW; Li SY; Tian YG; Lu XF; Jiang SL; Wang Y
BMC Complement Altern Med; 2014 Apr; 14():140. PubMed ID: 24766819
[TBL] [Abstract][Full Text] [Related]
6. Effective-component compatibility of Bufei Yishen formula III ameliorated COPD by improving airway epithelial cell senescence by promoting mitophagy via the NRF2/PINK1 pathway.
Li MY; Qin YQ; Tian YG; Li KC; Oliver BG; Liu XF; Zhao P; Li JS
BMC Pulm Med; 2022 Nov; 22(1):434. PubMed ID: 36414945
[TBL] [Abstract][Full Text] [Related]
7. Effective-compound combination of Bufei Yishen formula III combined with ER suppress airway mucus hypersecretion in COPD rats: via EGFR/MAPK signaling.
Xu K; Ma J; Lu R; Shao X; Zhao Y; Cui L; Qiu Z; Tian Y; Li J
Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 36799253
[TBL] [Abstract][Full Text] [Related]
8. [Compatibility characteristics of Bufei Yishen formula III in regulating chronic obstructive pulmonary disease mucus hypersecretion].
Qin Y; Li M; Tian Y; Zhao P; Li K; Li C; Li J
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Nov; 33(11):1309-1314. PubMed ID: 34980299
[TBL] [Abstract][Full Text] [Related]
9. System biology analysis of long-term effect and mechanism of Bufei Yishen on COPD revealed by system pharmacology and 3-omics profiling.
Li J; Zhao P; Yang L; Li Y; Tian Y; Li S
Sci Rep; 2016 May; 6():25492. PubMed ID: 27146975
[TBL] [Abstract][Full Text] [Related]
10. Effective-component compatibility of Bufei Yishen formula alleviates chronic obstructive pulmonary disease inflammation by regulating GSK3β-mediated NLRP3 inflammasome activation.
Qin Y; Zhai J; Yang J; Li H; Tian Y; Liu X; Zhao P; Li J
Biomed Pharmacother; 2023 Dec; 168():115614. PubMed ID: 37862971
[TBL] [Abstract][Full Text] [Related]
11. Long-term effects of Tiaobu Feishen therapies on systemic and local inflammation responses in rats with stable chronic obstructive pulmonary disease.
Li JS; Li Y; Li SY; Wang YY; Deng L; Tian YG; Jiang SL; Wang Y
Zhong Xi Yi Jie He Xue Bao; 2012 Sep; 10(9):1039-48. PubMed ID: 22979936
[TBL] [Abstract][Full Text] [Related]
12. [Effect of Yifei Jianpi Recipe on Airway Inflammation and Airway Mucus Hypersecretion of Chronic Obstructive Pulmonary Disease Model Rats].
Wang S; Xiong LL; Ren W; Zhu CD; Li CY; Zhou Q
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Aug; 35(8):993-9. PubMed ID: 26485917
[TBL] [Abstract][Full Text] [Related]
13. Systems pharmacology-based dissection of mechanisms of Chinese medicinal formula Bufei Yishen as an effective treatment for chronic obstructive pulmonary disease.
Li J; Zhao P; Li Y; Tian Y; Wang Y
Sci Rep; 2015 Oct; 5():15290. PubMed ID: 26469778
[TBL] [Abstract][Full Text] [Related]
14. Effective-constituent compatibility-based analysis of Bufei Yishen formula, a traditional herbal compound as an effective treatment for chronic obstructive pulmonary disease.
Li JS; Liu XF; Dong HR; Zheng WC; Feng SX; Tian YG; Zhao P; Ma JD; Ren ZX; Xie Y
J Integr Med; 2020 Jul; 18(4):351-362. PubMed ID: 32565294
[TBL] [Abstract][Full Text] [Related]
15. Integration of transcriptomics, proteomics, metabolomics and systems pharmacology data to reveal the therapeutic mechanism underlying Chinese herbal Bufei Yishen formula for the treatment of chronic obstructive pulmonary disease.
Zhao P; Li J; Yang L; Li Y; Tian Y; Li S
Mol Med Rep; 2018 Apr; 17(4):5247-5257. PubMed ID: 29393428
[TBL] [Abstract][Full Text] [Related]
16. [Electroacupuncture improves lung function by suppressing mucin-5AC mediated EGFR-p38MAPK signaling and inflammation reaction in chronic obstructive pulmonary disease rats].
Lin XG; Li W; Xiang SY; Wu SB; Zhang XF; Jiang CW; Liu ZB; Chen YN
Zhen Ci Yan Jiu; 2021 Mar; 46(3):180-6. PubMed ID: 33798289
[TBL] [Abstract][Full Text] [Related]
17. Maintenance of airway epithelial barrier integrity via the inhibition of AHR/EGFR activation ameliorates chronic obstructive pulmonary disease using effective-component combination.
Wei Y; Liu X; Jiang Y; Guan Q; Tian Y; Li J; Zhao P
Phytomedicine; 2023 Sep; 118():154980. PubMed ID: 37499344
[TBL] [Abstract][Full Text] [Related]
18. Tiao-bu-fei-shen formula promotes downregulation of the caveolin 1-p38 mapk signaling pathway in COPD - Associated tracheobronchomalacia cell model.
Zhou P; Yu W; Zhang C; Chen K; Tang W; Li X; Liu Z; Xia Q
J Ethnopharmacol; 2022 Jul; 293():115256. PubMed ID: 35367574
[TBL] [Abstract][Full Text] [Related]
19. Bufei Yishen formula protects the airway epithelial barrier and ameliorates COPD by enhancing autophagy through the Sirt1/AMPK/Foxo3 signaling pathway.
Jia L; Liu X; Liu X; Guan Q; Tian Y; Li J; Zhao P
Chin Med; 2024 Feb; 19(1):32. PubMed ID: 38413976
[TBL] [Abstract][Full Text] [Related]
20. Effects and mechanism of bufei yishen formula in a rat chronic obstructive pulmonary disease model.
Li J; Yang L; Yao Q; Li Y; Tian Y; Li S; Jiang S; Wang Y; Li X; Guo Z
Evid Based Complement Alternat Med; 2014; 2014():381976. PubMed ID: 24959185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
